In a May 12 Q&A, Dr. Gordon said the shutdown of elective care and research laboratories made it impossible for most informal interactions between colleagues (where innovative ideas are often born) to occur. She also said it prevented clinical studies from happening, which are often required to develop and test innovative products and treatments.
She said surgical innovation is delayed by a lack of funding. With hospitals still recovering from the elective surgery revenue they lost, they don’t have money for innovation investments or new products. With fewer innovations funded, the pipeline gets smaller.
To overcome these delays, Dr. Gordon recommended more community engagement across the research process, more inclusive clinical research participation and dissemination of innovative products in a culturally competent way.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
